Although VEGF-C enhances transport to the draining LNs and antigen exposure to the adaptive immune system, it can have negative effect on tumor immunity by activating tumor-surrounding cells, inducing aberrant lymphangiogenesis, and promoting immune tolerance. The gene discussed is VEGFC; the disease is neoplasm.